Related Experiment Video
Updated: Jun 8, 2026

11:36
Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Published on: May 29, 2020
Does inflammation play a role in kava hepatotoxicity?
Phytotherapy Research : PTR
|September 16, 2010
Summary
The exact cause of kava-induced liver damage is unknown, but toxic compounds, inflammation, and genetic factors may play a role. Further research is needed to understand kava
Area of Science:
- Pharmacology
- Hepatology
- Toxicology
Background:
- Kava kava consumption is linked to liver injury, but its precise mechanisms remain unclear.
- Existing evidence suggests roles for kava's toxic metabolites, cyclooxygenase (COX) inhibition, and glutathione depletion in hepatotoxicity.
- Genetic variations, particularly in Cytochrome P450 genes, are suspected to influence individual susceptibility.
Discussion:
- Hepatotoxicity cases present with hepatitis, indicating liver inflammation.
- The inflammatory response could be a direct effect of kava components or an indirect consequence of their metabolic pathways.
- Investigating the interplay between kava constituents and host factors is crucial.
Key Insights:
- The pathophysiology of kava hepatotoxicity is multifactorial, involving toxic metabolites and potential genetic predispositions.
- Cyclooxygenase (COX) enzyme inhibition and liver glutathione depletion are implicated in kava-induced liver injury.
- The direct versus indirect causation of hepatitis by kava requires further elucidation.
Outlook:
- Future research should focus on identifying specific toxic kava metabolites and their interactions with host pharmacogenomics.
- Clinical and experimental studies are needed to differentiate direct cellular damage from indirect inflammatory pathways.
- Understanding these mechanisms will aid in developing strategies for preventing and managing kava hepatotoxicity.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Gastritis-II: Pathophysiology
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...

